Small Pharma Agency vs Large Agency: How Specialists Win
Pharma brand teams default to large agencies for safety, not results. See how a small pharma agency vs large agency decision shifts when sp…
Pharma brand teams default to large agencies for safety, not results. See how a small pharma agency vs large agency decision shifts when sp…
Pharma e-detailer localization automation cuts three-day copy workflows to a single round trip — here's what works when AI handles the mech…
AI tools for pharma content production cut MLR cycles by removing pre-review friction — brand compliance, WCAG checks, modular claims. Here…
Patient info sites are outside the European Accessibility Act scope today, but pharma teams risk costly retrofits by waiting. Start WCAG 2.…
Pharma website accessibility under WCAG 2.2 AA is now law via the European Accessibility Act. See what MSD's hpvinfo.be got right — and her…
Pharma disease-awareness sites systematically fail WCAG 2.2 AA — and the European Accessibility Act makes that a legal risk. Here's what wo…
A pharma website accessibility audit of 80 disease awareness sites revealed contrast failures, broken PDFs, and WCAG gaps hurting vulnerabl…
AI content governance in pharma starts with your content stack, not your tool choice. Build validated claims, a knowledge hub, and semantic…
A pharma claims repository turns MLR-approved statements into reusable, tagged assets—cutting review cycles and preventing expired content…
A design system accessibility audit fixes WCAG failures in tokens and components before they spread across every pharma site. Here's what w…
A WCAG audit for pharma websites combines automated crawling with expert designer review to meet European Accessibility Act requirements —…
A custom Figma plugin for pharma design systems enforces brand tokens, WCAG 2.2, and MLR rules at source — cutting review rounds from weeks…
One short email when we publish. No spam, no sales pitch. Unsubscribe whenever.